Are you Dr. Paschke?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 51 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
34th & Civic Center Blvd
Children's Hospital Of Philadelphia
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-590-2204- Is this information wrong?
Summary
- Dr. Amanda Paschke, MD is a pediatric infectious disease specialist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Infectious Diseases, 2007 - 2010- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2004 - 2007
State University of New York Downstate Medical Center College of MedicineClass of 2004
Certifications & Licensure
PA State Medical License 2004 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 18 citationsEvaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phas...Michelle L Brown, Johann Motsch, Keith S Kaye, Thomas M. File, Helen W. Boucher, Neika Vendetti, Angela Aggrey, Hee-Koung Joeng, Robert W. Tipping, Jiejun Du, Daryl D....> ;Open Forum Infectious Diseases. 2020 Feb 19
- 126 citationsPhase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal InfectionChristopher Lucasti, Liviu Vasile, Dorel Sandesc, Donatas Venskutonis, Patrick McLeroth, Mallika Lala, Matthew L. Rizk, Michelle L Brown, Maria C Losada, Alison Pedley...> ;Antimicrobial Agents and Chemotherapy. 2016 Sep 23
- 66 citationsPrevious Antimicrobial Exposure Is Associated With Drug-Resistant Urinary Tract Infections in ChildrenAmanda A. Paschke, Theoklis E. Zaoutis, Patrick H. Conway, Dawei Xie, Ron Keren> ;Pediatrics. 2010 Apr 1
Press Mentions
Results of Phase 2 Study of Merck’s Investigational Beta-Lactamase Inhibitor Relebactam in Combination with Imipenem/Cilastatin Presented at ASM MicrobeJune 20th, 2016
